Xylo Technologies Ltd. - ADR
XYLO
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.77M
Close$
Share Statistics
| Market cap | $3.77 Million |
|---|---|
| Enterprise Value | $1.88 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.36 |
| Beta | 0.17 |
| Outstanding Shares | 773,466 |
Return
| Return on Equity | -33.51% |
|---|---|
| Return on Assets | -16.05% |
| Return on Invested Capital | -44.41% |
Valuation & Multiples
| P/E Ratio | -0.61 |
|---|---|
| PEG | 0.54 |
| Price to Sales | 0.13 |
| Price to Book Ratio | 0.23 |
| Enterprise Value to Revenue | 0.06 |
| Enterprise Value to EBIT | -0.22 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.65 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Xylo Technologies Ltd.
26 employees
CEO: Liron Carmel medical device company focused on innovative endoscopic procedures and devices. medigus developed an entire endoscopic system for intraluminal treatment of gerd (gastroesophageal reflux disease), one of the most common chronic diseases i...